The abstract is read at the publisher; the summary is JClub's.
Engineered AIRE expression in tumor cells resets their “selfness” and exposes them to T-cell attack, enabling potent rejection of aggressive, immunologically cold, nonimmunogenic tumors.
- Why it matters: Tumors can evade immunity by mimicking thymic tolerance, leaving many cancers “cold” and resistant to immune therapies; a way to reprogram tumor tolerance is needed.
- What they did: The study showed AIRE induces a selfness profile at RNA and protein levels that, when presented on MHC, shields tumors from self-tolerized T cells, and tested in vivo immunotherapy using engineered AIRE changes in tumor cells.
- The result: AIRE conditioning converted a tolerized T-cell compartment into tumor-reactive cells, conferred de novo sensitivity to immune checkpoint blockade, and patient RNA sequencing data showed AIRE expression strongly correlates with T-cell receptor signaling markers and predicted response to immune therapies.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.